| # | Drug | Count |
|---|---|---|
| 0 | CANAGLIFLOZIN | 269 |
| 1 | EMPAGLIFLOZIN | 21 |
| 2 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 15 |
| 3 | METFORMIN | 13 |
| 4 | METFORMIN ER 500 MG | 13 |
| 5 | METFORMIN ER 750 MG | 13 |
| 6 | INSULIN GLARGINE | 10 |
| 7 | ASPIRIN | 9 |
| 8 | ASPIRIN 325 MG | 7 |
| 9 | ASPIRIN 81 MG | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANAGLIFLOZIN | 269 | 0.0090 |
| 1 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 15 | 0.0083 |
| 2 | ANGIOTENSIN II | 2 | 0.0067 |
| 3 | DIFELIKEFALIN | 1 | 0.0024 |
| 4 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | 0.0021 |
| 5 | PENICILLIN G POTASSIUM | 1 | 0.0014 |
| 6 | DOPAMINE HYDROCHLORIDE | 5 | 0.0013 |
| 7 | VASOPRESSIN | 4 | 0.0009 |
| 8 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 9 | PENICILLIN G BENZATHINE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 24 |
| 1 | Insulin Analog [EPC] | 15 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 9 |
| 4 | Catecholamine [EPC] | 8 |
| 5 | Loop Diuretic [EPC] | 7 |
| 6 | Corticosteroid [EPC] | 6 |
| 7 | Proteasome Inhibitor [EPC] | 6 |
| 8 | Proton Pump Inhibitor [EPC] | 6 |
| 9 | Alkylating Drug [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 2 | 0.0067 |
| 1 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 4 | Glinide [EPC] | 2 | 0.0002 |
| 5 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 24 | 0.0002 |
| 6 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Catecholamine [EPC] | 8 | 0.0001 |
| 8 | Antimalarial [EPC] | 1 | 0.0001 |
| 9 | Antiprotozoal [EPC] | 1 | 0.0001 |